当前位置:
X-MOL 学术
›
Cancer Discov.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
SHP2 Inhibition May Resensitize NSCLC Tumors to ALK Inhibitors
Cancer Discovery ( IF 29.7 ) Pub Date : 2018-05-01 , DOI: 10.1158/2159-8290.cd-rw2018-043 American Association for Cancer Research
中文翻译:
SHP2抑制作用可能会使NSCLC肿瘤对ALK抑制剂重新敏感
更新日期:2018-05-01
Cancer Discovery ( IF 29.7 ) Pub Date : 2018-05-01 , DOI: 10.1158/2159-8290.cd-rw2018-043 American Association for Cancer Research
Targeting SHP2 suppresses ALK inhibitor resistance caused by tyrosine kinase reactivation.
中文翻译:
SHP2抑制作用可能会使NSCLC肿瘤对ALK抑制剂重新敏感
靶向SHP2可抑制酪氨酸激酶再激活引起的ALK抑制剂耐药性。